Abstract
The synthesis and characterisation of R3PAu[S 2CN(iPr)CH2CH2OH], for R = Ph (1), Cy (2) and Et (3)4, is reported. Compounds 1-3 are cytotoxic against the doxorubicin-resistant breast cancer cell line, MCF-7R, with 1 exhibiting greater potency and cytotoxicity than either of doxorubicin and cisplatin. Based on human apoptosis PCR-array analysis, caspase activities, DNA fragmentation, cell apoptotic assays, intracellular reactive oxygen species (ROS) measurements and human topoisomerase I inhibition, induction of apoptosis by 1, and necrosis by 2 and 3, are demonstrated, by both extrinsic and intrinsic pathways. Compound 1 activates the p53 gene, 2 activates only the p73 gene, whereas 3 activates both the p53 and p73 genes. Compounds 1 and 3 activate NF-κB, and each inhibits topoisomerase I. © 2013 Elsevier Masson SAS. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Jamaludin, N. S., Goh, Z. J., Cheah, Y. K., Ang, K. P., Sim, J. H., Khoo, C. H., … Tiekink, E. R. T. (2013). Phosphanegold(I) dithiocarbamates, R3PAu[SC(=S)N( iPr)CH2CH2OH] for R = Ph, Cy and Et: Role of phosphane-bound R substituents upon in vitro cytotoxicity against MCF-7R breast cancer cells and cell death pathways. European Journal of Medicinal Chemistry, 67, 127–141. https://doi.org/10.1016/j.ejmech.2013.06.038
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.